Francis Willard
0000-0002-4260-2451
2 papers found
Refreshing results…
Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist
The current state of GPCR-based drug discovery to treat metabolic disease: GPCR drug discovery for metabolic diseases
Missing publications? Search for publications with a matching author name.